The Patent Finder

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Merck & Cie

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 62/296,296, filed Feb 17, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,059,710Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
In force
 · High confidence
Merck & CieIn force
High confidence
US 10,336,758New stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
In force
 · High confidence
Merck & CieIn force
High confidence
US 10,570,134Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
In force
 · High confidence
Merck & CieIn force
High confidence
US 11,306,094Stable Formulations of 5,10-Methylene-(6R)-TETRAHYDROFOLIC Acid
In force
 · High confidence
Merck & CieIn force
High confidence
US 12,103,930Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
In force
 · High confidence
Merck & CieIn force
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited